Health Care [ 8/12 ] | Life Sciences Tools & Services [ 55/76 ]
NASDAQ | Common Stock
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions.
It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.
The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions.
It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment.
In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation.
Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Feb 17, 26 | 0.59 Decreased by -22.37% | 0.65 Decreased by -9.09% |
| Nov 4, 25 | 0.45 Decreased by -25.00% | 0.32 Increased by +40.63% |
| Aug 4, 25 | 0.05 Decreased by -90.38% | 0.08 Decreased by -37.50% |
| May 7, 25 | 0.47 Decreased by -11.32% | 0.44 Increased by +6.82% |
| Feb 13, 25 | 0.76 Decreased by -5.00% | 0.74 Increased by +2.70% |
| Nov 5, 24 | 0.60 Decreased by -18.92% | 0.60 |
| Aug 6, 24 | 0.52 Increased by +4.00% | 0.52 |
| May 2, 24 | 0.53 Decreased by -17.19% | 0.46 Increased by +15.22% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 25 | 977.20 M Decreased by -0.24% | 26.00 M Increased by +89.78% | Increased by +2.66% Increased by +90.25% |
| Sep 30, 25 | 860.50 M Decreased by -0.45% | -59.60 M Decreased by -245.72% | Decreased by -6.93% Decreased by -246.38% |
| Jun 30, 25 | 797.40 M Decreased by -0.41% | 7.60 M Increased by 0.00% | Increased by +0.95% Increased by +0.41% |
| Mar 31, 25 | 801.40 M Increased by +11.04% | 17.40 M Decreased by -65.82% | Increased by +2.17% Decreased by -69.22% |
| Dec 31, 24 | 979.60 M Increased by +14.64% | 13.70 M Decreased by -93.33% | Increased by +1.40% Decreased by -94.18% |
| Sep 30, 24 | 864.40 M Increased by +16.37% | 40.90 M Decreased by -53.58% | Increased by +4.73% Decreased by -60.11% |
| Jun 30, 24 | 800.70 M Increased by +17.42% | 7.60 M Decreased by -86.69% | Increased by +0.95% Decreased by -88.66% |
| Mar 31, 24 | 721.70 M Increased by +5.31% | 50.90 M Decreased by -33.46% | Increased by +7.05% Decreased by -36.82% |